This study assessed the impact of frailty in patients with advanced heart failure on clinical outcomes after heart transplantation (HTx).
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transplantation - Heart
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes
April 16, 2020
The UNOS donor heart allocation system was revised in 2018, giving priority to patients on inpatient mechanical circulatory support (MCS). Patients admitted with heart failure-associated cardiogenic shock were tracked for the frequency of use of mechanical circulatory support before and after implementation of this change. In non-transplant center
In Situ Expansion, Differentiation and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid
April 2, 2020
Quite refreshing well-written experimental paper leaving promises of artificial organoids.
August 23, 2019
Excellent and brief summary of the debate on functional mitral regurgitation on mechanical support.
August 13, 2019
The translational value for cardiac transplantation of this prospective multi-centre clinical study of vasodilation in amyloidosis remains to be evaluated.
June 4, 2019
Left ventricular ejection fraction was not a predictor of outcomes after heart transplant, and was normal in all recipients at 1 year posttransplant. The reliance on generic transthoracic echocardiography for donor assessment may well be the Achilles heel of this retrospective case study.
May 30, 2019
This lecture was presented during the Glasgow Cardiopulmonary Transplantation and Mechanical Circulatory Support Symposium, a one-day symposium held at the Golden Jubilee National Hospital in Glasgow, UK.
May 21, 2019
The authors utilized a retrospective review of the UNOS database from 2007-2014 to evaluate the impact of donor sequence number (DSN) on outcomes.
In Global News: Cardiac Regeneration in Pigs, Health Effects of Marijuana Use, and Running to Reduce Aortic Stiffness
May 10, 2019
Patient Care and General Interest
April 28, 2019
The authors of this single-center open-label pilot trial evaluated the intermediate-term outcomes of patients undergoing either heart (n=8) or lung (n=36) transplantation from donors that had evidence of active hepatitis C virus (HCV) infection. All patients underwent treatment of HCV antiviral treatment for 4 weeks after transplantation.